The quest to understand and interpret the human genome has fueled the development of a unique set of companies within the molecular biology tools sector.

These companies provide multiple technologies across the sequencing, genomics, proteomics, and metabolomics markets. All of these companies are wrestling with the financial demands of growing their businesses in a market that is moving as fast as 21st century science and innovation will allow.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.